Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Tendler Craig — DelMar Pharmaceuticals, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Tendler Craig

Tendler Craig

Director at DelMar Pharmaceuticals, Inc. · on record since Mar 19, 2025

Insider trading activity of Tendler Craig

Transactions on record: 2; since Mar 19, 2025

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 17, 2026

Figures computed from official regulatory filings — methodology.

Companies where Tendler Craig has traded

DelMar Pharmaceuticals, Inc.2 tx · Feb 17, 2026

Track record of Tendler Craig

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Tendler Craig

Co-insiders of Tendler Craig

BACHA JEFFREYDelMar Pharmaceuticals, Inc.
Bahouth Donald G.DelMar Pharmaceuticals, Inc.
Bell John KDelMar Pharmaceuticals, Inc.
BIANCO JAMES ADelMar Pharmaceuticals, Inc.
Brown Dennis MDelMar Pharmaceuticals, Inc.
Cranston Lynda SarahDelMar Pharmaceuticals, Inc.
Dearborn DanDelMar Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Douglass Laura L.DelMar Pharmaceuticals, Inc.

Ferrara NapoleoneDelMar Pharmaceuticals, Inc.

FUGUET HOWARD KDelMar Pharmaceuticals, Inc.

Garner William JDelMar Pharmaceuticals, Inc.

HOFFMAN ROBERTDelMar Pharmaceuticals, Inc.

Liatos JohnDelMar Pharmaceuticals, Inc.

List AlanDelMar Pharmaceuticals, Inc.

MANUSO JAMES S JDelMar Pharmaceuticals, Inc.

Mohr ErichDelMar Pharmaceuticals, Inc.

Murphy KeithDelMar Pharmaceuticals, Inc.

Ng George KDelMar Pharmaceuticals, Inc.

Patel VijayDelMar Pharmaceuticals, Inc.

Praill ScottDelMar Pharmaceuticals, Inc.

SEYMOUR TAMARA ADelMar Pharmaceuticals, Inc.

TOTH ROBERT JOSEPH JRDelMar Pharmaceuticals, Inc.

Vollintine Raymond L.DelMar Pharmaceuticals, Inc.

Yamashita DennisDelMar Pharmaceuticals, Inc.

Zarrabian SaiidDelMar Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
DelMar Pharmaceuticals, Inc.	Feb 17, 2026	AwardD	156,240	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Mar 19, 2025	AwardD	151,883	0.00 USD	$0	SEC